Literature DB >> 17681125

HDAC6-pack: cortactin acetylation joins the brew.

G W Gant Luxton1, Gregg G Gundersen.   

Abstract

The reversible acetylation of lysine residues is an important posttranslational modification for the regulation of histones, transcription factors, chaperones, and microtubules. In a recent article in Molecular Cell, Zhang et al. (2007) describe a new target of reversible acetylation, the actin binding protein cortactin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681125     DOI: 10.1016/j.devcel.2007.07.014

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  7 in total

Review 1.  The role of HDAC6 in cancer.

Authors:  Grace I Aldana-Masangkay; Kathleen M Sakamoto
Journal:  J Biomed Biotechnol       Date:  2010-11-07

Review 2.  Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates.

Authors:  Ya-Li Yao; Wen-Ming Yang
Journal:  J Biomed Biotechnol       Date:  2010-12-22

3.  HDAC6 regulates dental mesenchymal stem cells and osteoclast differentiation.

Authors:  Yi Wang; Zhi Yun Shi; Jin Feng; Jun Kai Cao
Journal:  BMC Oral Health       Date:  2018-11-21       Impact factor: 2.757

Review 4.  Next-generation of selective histone deacetylase inhibitors.

Authors:  Feifei Yang; Na Zhao; Di Ge; Yihua Chen
Journal:  RSC Adv       Date:  2019-06-24       Impact factor: 4.036

5.  Loss of Deacetylation Enzymes Hdac6 and Sirt2 Promotes Acetylation of Cytoplasmic Tubulin, but Suppresses Axonemal Acetylation in Zebrafish Cilia.

Authors:  Paweł K Łysyganicz; Niedharsan Pooranachandran; Xinming Liu; Kathryn I Adamson; Katarzyna Zielonka; Stone Elworthy; Fredericus J van Eeden; Andrew J Grierson; Jarema J Malicki
Journal:  Front Cell Dev Biol       Date:  2021-06-28

6.  Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines.

Authors:  Alejandro Urdiciain; Elena Erausquin; María V Zelaya; Idoya Zazpe; José L Lanciego; Bárbara Meléndez; Juan A Rey; Miguel A Idoate; Natalia A Riobo-Del Galdo; Javier S Castresana
Journal:  Biology (Basel)       Date:  2021-05-26

Review 7.  HDAC6 and ovarian cancer.

Authors:  Joshua Haakenson; Xiaohong Zhang
Journal:  Int J Mol Sci       Date:  2013-05-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.